What We’re Reading: Hospitals’ Pursuit of Profits; Opioid Crisis Funding; Arizona Abortion Ban
Nonprofit hospitals pursue profits from low-income patients; the Biden administration announced that $1.5 billion would be set aside to battle opioid overdoses and support recovery; an Arizona judge ruled that a state law that criminalizes nearly all abortions could take effect immediately.
Novel Therapies for SMA Have Changed the Way Patients Are Classified, Dr Vamshi Rao Explained
The new therapies for spinal muscular atrophy (SMA) have had such a profound impact on disease trajectory that classification terminology has been changed, said Vamshi Rao, MD, attending physician, Children’s Hospital of Chicago, and assistant professor, Northwestern University Feinberg School of Medicine.
What We’re Reading: 340B Drugs Marked Up; Minnesota Nurses Strike; Cancer Drug Tops Chemotherapy
340B hospitals are marking up discounted drugs by 4.9 times the cost, per a Community Oncology Alliance report; thousands of nurses in Minnesota are striking due to understaffing and overworking; Amgen’s sotorasib performed better than a common chemotherapy for progression-free survival among patients.
Dr Igor Puzanov Discusses the State of Adjuvant Therapy for Advanced Melanoma
In this interview with The American Journal of Managed Care® (AJMC®), Igor Puzanov, MD, of Roswell Park Comprehensive Cancer Center and Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, discusses the state of treatment selection in the setting of resected advanced melanoma, why sequencing of therapies does not occur in the setting of adjuvant therapy, and best practices to keep in mind for patient education and managing their treatment-related toxicities.
What We’re Reading: Biden Boosts Biotech; 9/11 Program Nearly Depleted; Tpoxx Safe in Monkeypox
President Joe Biden is set to sign an order to boost biotech as part of his Cancer Moonshot; the health care program for 9/11 survivors and first responders is running short on money; tecovirimat (Tpoxx) has been found to be safe in patients with monkeypox.